It is with reluctance and sadness that, due to the global impact of the COVID-19 pandemic, the May Measurement Month (MMM) Global Project Team has made the decision that MMM20 should not take place this year.
We hope that volunteers will understand and support this decision. We look forward to planning MMM21 together.
The organizing committee of the 2020 ESH-ISH Joint Meeting in Glasgow, would like to inform you that in view of the global unprecedented situation related to COVID-19, the ESH-ISH Joint Meeting, has been rescheduled to April 11-14, 2021.
The International Society of Hypertension (ISH) is aware of concern raised by speculation, which was amplified by the media and which suggested that hypertension (raised blood pressure) increases susceptibility to infection with COVID-19. Further speculation reportedly suggested that two commonly used classes of blood pressure lowering agents (ACE-Inhibitors and Angiotensin Receptor Blockers (ARBs)) may worsen the outcome for those who are infected with COVID-19 (1).
The ISH completely endorses the content of two recent statements made by the Council on Hypertension of the European Society of Cardiology and the European Society of Hypertension (2,3) both of which made clear that there is no good evidence to change the use of ACE-inhibitors or ARBs for the management of raised blood pressure in the context of avoiding or treating COVID-19 infection.
ISH-supported Online Course aims to help program managers and implementers in designing, planning, and implementing a hypertension control program.
The ISH is pleased to support our educational partner Omron Heathcare in the launch of a new online curriculum on hypertension.
STRIDE BP provides lists of accurate devices for office, home and ambulatory…
The ISH is pleased to announce that Professor Maciej Tomaszewski is the President-Elect of the Society. He will take up the Presidential office at the conclusion of the ISH/ESH 2020 meeting in Glasgow
You are viewing articles tagged with "During 09/2017".
Join us at the ISH New Investigator Programme (Symposium / Mentorship & Networking Event), Singapore, 6 October 2017
The International Society of Hypertension (ISH) New Investigator Committee (NIC) and Mentorship and Training Committee (MTC) are working closely with the organisers of the forthcoming APCH 2017, October, Singapore Meeting (13th Asian Pacific Congress of Hypertension) – www.apch2017.org).
To recognise and bring together hypertension future leaders, we will be hosting a New Investigator Symposium on the morning of 6 October (from 09:00-13:00 hrs), followed by a Networking and Mentorship event on the evening of 6 October.
Attendance is welcomed from all investigators (young / new and more senior investigators).
Read More 29/09/2017
PHFI awarded the prestigious QCI-DL Shah Platinum Award for skill building of primary care physicians in chronic conditions in India.
Read More 25/09/2017
Join us in congratulating our September 2017 ISH New Investigator of the month, Kento Kitada, Ph.D., from the Department of Pharmacology, Faculty of Medicine, Kagawa University, Japan.
Read More 06/09/2017